August 1, 2011
CASE CCC IN THE NEWS
Cleveland Clinic Doctors Link Esophageal Cancer to Genes
Your Medical Family Tree
Dr. Brian Bolwell Named Chairman of Taussig Cancer Institute
Congratulations to Dr. Brian Bolwell, who was recently appointed as Chairman of the Taussig Cancer Institute. Dr. Bowell is currently Professor of Hematology & Medical Oncology, and has served as interim chair since late last year when Dr. Derek Raghavan resigned. Please join us in congratulating Dr. Bolwell in his new role!
Case CCC Clinical Trials Standard Operating Procedures (SOPs)
The Case CCC has posted clinical trials Standard Operating Procedures (SOPs) on the Clinical Research Portal website. SOPs apply to those members of the clinical research teams who are involved in conducting cancer research and clinical trials at the Case CCC. The Cancer Center implements and enforces all SOPs across consortium institutions: Case Western Reserve University, Cleveland Clinic and University Hospitals. Questions about the SOPs should be directed to Katarzyna Karelus, Administrative Director, Clinical Research Office, 216-368-6287 or email@example.com.
Clinical Research Scholar Career Development Training Opportunity
The CTSC KL2 seeks outstanding candidates to fill Clinical Research (CR) Scholar positions available in July 2012. The training program is funded by the NIH and it is a component of the Cleveland Clinical and Translational Science Collaborative. This innovative program is a collaboration involving CWRU, Cleveland Clinic, UH and MetroHealth. Each CR Scholar will embark on a 4-year program of intensive training in interdisciplinary team-based, patient-oriented research, combining a novel educational program with mentored research experiences.
Interested applicants are encouraged to attend upcoming informational sessions. To make a reservation, please contact contact Beth Spyke, MPA at firstname.lastname@example.org or 216-444-2702. Applications will be accepted through October 10.
MARK YOUR CALENDARS
Minority Recruitment and Cancer Research Retreat
Mark your calendars for the Minority Recruitment and Cancer Research Retreat, August 30 from 3-6 pm in the Wolstein Research Building Auditorium. Please join us as we explore in a retreat setting (plenary and break-out sessions) issues related to minority recruitment to cancer clinical trials. Registration will be required due to a limited space. Stay tuned!
Imaging Solutions In Cancer Management: A Case-Based Conference
Registration is now open for Imaging Solutions In Cancer Management: A Case-Based Conference. Join us September 8 for this comprehensive oncologic imaging course, which focuses on cancer management using imaging as a diagnostic tool and as a guide for minimally invasive therapeutic applications. This course takes a practical approach using cases and features multiple specialists ranging from medical oncologists, radiation oncologists, surgeons, radiologists and basic scientists.
This conference will be simultaneously broadcast on line. See the brochure for details.
NCI CANCER BULLETIN
July 26, 2011- Special Issue: Adolescent and Young Adult Cancers
**All events are open to anyone interested in attending
Cancer Imaging Program Special Presentation
School of Dental Medicine Seminar
Hematology and Oncology Research Conference
Stem Cell Biology and Regenerative Medicine Seminar
Olof Pearson Lecture
Cancer Center Research in Progress Seminar will resume September 2.
Hematology/Oncology Fellows Curriculum Series
Hematology/Oncology Fellows Curriculum Series
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Imaging Solutions in Cancer Management: A Case-based Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS
MSC 2011: Innovations in Cell-Based Regenerative Therapies
First Ascoli Piceno Conference on Gene Vaccination in Cancer
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
Multiple Myeloma Research Foundation (MMRF) Biotech Investment Award
The Multiple Myeloma Research Foundation (MMRF) seeks proposals for its Biotech Investment Award program (BIA). The goal of this initiative is to drive and accelerate the development of innovative and effective treatments for myeloma. By funding the early stages of drug discovery and development, BIA will have significant impact on future myeloma treatments.
LOI Deadline: August 23
St. Baldrick's Foundation Infrastructure Grants
St. Baldrick's Foundation has released a call for applications for Infrastructure Grants. These grants are intended for institutions with the potential to participate significantly more in childhood cancer clinical trials, but which are smaller or have barriers to greater participation due to a lack of resources. Preference will be given to institutions that serve populations which might have limited access to participation in clinical trials without access to appropriately resourced institutions.
Deadline: September 6
Hope Funds for Cancer Research Postdoctoral Fellowship
The Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS. The Trustees of the Hope Funds believe that funding research that could lead to breakthroughs in these areas and increase life expectancy in these types of cancers is at the core of its mission. The Fellowship Review Committee will consider each of the following criteria, with a strong emphasis on the innovation of the project, in evaluating candidates.
Proposal Deadline: September 16
FY11 Breast Cancer Research Program (BCRP)
The Breast Cancer Research Program (BCRP) has released two more funding opportunities:
The BCRP Clinical Translational Research (CTR) Award is intended to promote significant improvements over current approaches to breast cancer prevention and therapy, such as studies that would better align treatment options with more specific breast cancer subtypes, vaccine studies that will prevent primary or recurrent breast cancer, and studies that may result in a new treatment to prevent breast cancer progression to metastasis. The CTR Award supports research projects that are likely to have a major impact on breast cancer by applying promising research findings to patients with, or populations at risk for, breast cancer.
Pre-Application Deadline: September 20
The BCRP Impact Award supports unique research projects or ideas (from small- to large-scale) that specifically focus on scientific and clinical breast cancer issues, which, if successfully addressed, could ultimately revolutionize the understanding, prevention, and/or treatment of breast cancer and make major advances towards the goal of eradicating the disease. The BCRP particularly encourages applications that focus on poorly understood issues that are of critical significance in breast cancer, such as those related to susceptibility, recurrence, or metastasis. The proposed work must be based on sound overall research and fully supported by preliminary data and/or published reports.
Pre-Application Deadline: September 20
DeGregorio Family Foundation for Stomach and Esophageal Cancer Research and Education
The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce a funding opportunity for gastroesophageal malignancies. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. We wish to support high quality and innovative bench, clinical, and translational research to improve our understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.
Deadline: November 1
Case CCC Clinical Trials Funding Opportunity
The Case Comprehensive Cancer Center is announcing the availability of Protocol Specific Research Support (PSRS) funding for Year 2011. The budgeted funds are for the conduct of early phase clinical trial and restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Studies developed jointly between UH and CCF with planned accrual at both institutions will be prioritized. Please direct questions and requests for information about the funding process to Katarzyna Karelus, Administrative Director, Case Comprehensive Cancer Center Clinical Research Office, at (216) 368-6287 or email@example.com.
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
CTSC Core Utilization Pilot Grants
Leukemia & Lymphoma Society (LLS) Scholar
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.